These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 1957798)
21. A shot in the arm for an AIDS vaccine. Newsweek; 1998 Jun; 131(24):62. PubMed ID: 10180631 [No Abstract] [Full Text] [Related]
22. Experimental AIDS drug d4T, now available to patients in critical need. Ann Allergy; 1993 Sep; 71(3):A24. PubMed ID: 8396862 [No Abstract] [Full Text] [Related]
23. AIDS therapy and the detection of adverse drug effects in dental practice. Arrowsmith JB J Am Dent Assoc; 1989 Nov; Suppl():46S-48S. PubMed ID: 2592694 [No Abstract] [Full Text] [Related]
24. Clinical trial that led to FDA approval of zidovudine is published. Clin Pharm; 1987 Oct; 6(10):752. PubMed ID: 3333341 [No Abstract] [Full Text] [Related]
25. From the Food and Drug Administration. Nightingale SL JAMA; 1990 Aug; 264(6):677. PubMed ID: 2197448 [No Abstract] [Full Text] [Related]
26. The fast track: federal agencies and the political demand for AIDS drugs. Foreman CH Brookings Rev; 1991; 9(2):30-7. PubMed ID: 10110828 [No Abstract] [Full Text] [Related]
27. AIDS: AZT for children in extended US trial. Lindley D Nature; 1989 Nov; 342(6245):10. PubMed ID: 2811993 [No Abstract] [Full Text] [Related]
28. AZT (zidovudine) just a step away from FDA approval for AIDS therapy. Marwick C JAMA; 1987 Mar; 257(10):1281-2. PubMed ID: 3469418 [No Abstract] [Full Text] [Related]
29. The FDA just says yes. MacPherson P Hosp Health Netw; 1996 May; 70(10):34-6, 38. PubMed ID: 8620201 [TBL] [Abstract][Full Text] [Related]
30. Experimental AIDS drug, d4T, now available to patients in critical need. Ann Allergy; 1993 Nov; 71(5):A-27. PubMed ID: 8250344 [No Abstract] [Full Text] [Related]
31. AIDS research intensifying: 88 medicines in testing, 14 approved. Infect Control Hosp Epidemiol; 1992 Mar; 13(3):170. PubMed ID: 1564316 [No Abstract] [Full Text] [Related]
32. FDA's proposed regulations to expand access to investigational drugs for treatment use: the status quo in the guise of reform. Rossen BR Food Drug Law J; 2009; 64(1):183-223. PubMed ID: 19998746 [TBL] [Abstract][Full Text] [Related]
33. The quiet drug revolution. Graham M Med Econ; 1991 Feb; 68(4):129-33. PubMed ID: 10109106 [TBL] [Abstract][Full Text] [Related]
34. Shaking up the status quo: how AIDS activists have challenged drug development and approval procedures. Dunbar MM Food Drug Cosmet Law J; 1991 Sep; 46(5):673-706. PubMed ID: 11651380 [No Abstract] [Full Text] [Related]
35. Rifabutin receives treatment IND status for AIDS-related use. Ann Pharmacother; 1992 Jun; 26(6):868. PubMed ID: 1319245 [No Abstract] [Full Text] [Related]
37. Approval of zidovudine (AZT) for acquired immunodeficiency syndrome. A challenge to the medical and pharmaceutical communities. Brook I JAMA; 1987 Sep; 258(11):1517. PubMed ID: 3306004 [No Abstract] [Full Text] [Related]
38. AIDS, activism, and ethics. Rothman DJ; Edgar H Hosp Pract (Off Ed); 1991 Jul; 26(7):135-42. PubMed ID: 2071678 [TBL] [Abstract][Full Text] [Related]
39. Fumes from the spleen. Paediatr Perinat Epidemiol; 1991 Jul; 5(3):258-60. PubMed ID: 1881836 [No Abstract] [Full Text] [Related]
40. When science and passion meet: the impact of AIDS on research. Pripstein J CMAJ; 1993 Feb; 148(4):638-42. PubMed ID: 8431829 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]